Literature DB >> 31419461

Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment.

Vedrana Savić1, Tanja Ilić1, Ines Nikolić1, Bojan Marković2, Bojan Čalija1, Nebojša Cekić3, Snežana Savić4.   

Abstract

Nanostructured lipid carriers (NLC) and nanoemulsions (NE) are colloid carriers which could improve dermal delivery of tacrolimus. The aims of this study were to evaluate effects of different formulation and process parameters on physicochemical characteristics and stability of lecithin-based NLC with glyceryl palmitostearate as solid and propylene glycol monocaprylate as liquid lipid and to compare the influence of different inner structure of tacrolimus-loaded NLC and corresponding NE on physicochemical characteristics, stability, entrapment efficiency, in vitro drug release and overall skin performance. Solid/liquid lipid ratio, total amount of lipids, homogenization pressure and cooling after the preparation were identified as critical variables in NLC development. Moreover, tacrolimus-loaded NLC emerged as more stabile carrier than NE. Differential stripping performed on porcine ear skin revealed significantly higher tacrolimus amount in stratum corneum from nanocarriers compared to referent ointment (Protopic®). Similarly the highest amount of tacrolimus in hair follicles was obtained using NLC (268.54 ± 92.38 ng/cm2), followed by NE (128.17 ± 48.87 ng/cm2) and Protopic® (77.61 ± 43.25 ng/cm2). Contrary, the highest permeation rate through full-thickness porcine ear skin was observed for Protopic®, implying that the selection of experimental setup is critical for reliable skin performance assessment. Overall, developed NLC could be suggested as promising carrier in a form of lotion for tacrolimus dermal delivery.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Capryol™ 90; Dermal drug delivery; Lecithin-based nanostructured lipid carriers; Nanoemulsion; Precirol® ATO 5; Tacrolimus

Mesh:

Substances:

Year:  2019        PMID: 31419461     DOI: 10.1016/j.ijpharm.2019.118624

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Chemical vs. Physical Methods to Improve Dermal Drug Delivery: A Case Study with Nanoemulsions and Iontophoresis.

Authors:  Ines Nikolić; Mitar Simić; Ivana Pantelić; Goran Stojanović; Jelena Antić Stanković; Bojan Marković; Snežana Savić
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

2.  Cutaneous innate immune tolerance is mediated by epigenetic control of MAP2K3 by HDAC8/9.

Authors:  Yu Sawada; Teruaki Nakatsuji; Tatsuya Dokoshi; Nikhil Nitin Kulkarni; Marc C Liggins; George Sen; Richard L Gallo
Journal:  Sci Immunol       Date:  2021-05-21

3.  Lecithin-Based Dermal Drug Delivery for Anti-Pigmentation Maize Ceramide.

Authors:  Kazuhiro Kagotani; Hiroko Nakayama; Liqing Zang; Yuki Fujimoto; Akihito Hayashi; Ryoji Sono; Norihiro Nishimura; Yasuhito Shimada
Journal:  Molecules       Date:  2020-03-31       Impact factor: 4.411

4.  Sorafenib-loaded nanostructured lipid carriers for topical ocular therapy of corneal neovascularization: development, in-vitro and in vivo study.

Authors:  Qing Luo; Jingjing Yang; Haohang Xu; Jieran Shi; Zhen Liang; Rui Zhang; Ping Lu; Guojuan Pu; Ningmin Zhao; Junjie Zhang
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.